Lexaria Bioscience Corp (LEXX)
2.16
-0.09
(-4.00%)
USD |
NASDAQ |
Apr 19, 16:00
2.16
0.00 (0.00%)
After-Hours: 20:00
Lexaria Bioscience Cash from Investing (TTM): -0.1991M for Feb. 29, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| February 29, 2024 | -0.1991M |
| November 30, 2023 | -0.1748M |
| August 31, 2023 | -0.1696M |
| May 31, 2023 | -0.1512M |
| February 28, 2023 | -0.1555M |
| November 30, 2022 | -0.1573M |
| August 31, 2022 | -0.1806M |
| May 31, 2022 | -0.1306M |
| February 28, 2022 | -0.1634M |
| November 30, 2021 | 0.1414M |
| August 31, 2021 | 0.1939M |
| May 31, 2021 | 0.1802M |
| February 28, 2021 | 0.2435M |
| November 30, 2020 | -0.0269M |
| August 31, 2020 | -0.0268M |
| May 31, 2020 | -0.0463M |
| February 29, 2020 | -1.278M |
| November 30, 2019 | -0.6077M |
| August 31, 2019 | -0.7692M |
| May 31, 2019 | -0.7628M |
| February 28, 2019 | 0.4498M |
| November 30, 2018 | -0.2369M |
| August 31, 2018 | -0.1554M |
| May 31, 2018 | -0.1286M |
| February 28, 2018 | -0.102M |
| Date | Value |
|---|---|
| November 30, 2017 | -0.0817M |
| August 31, 2017 | -0.0097M |
| May 31, 2017 | -0.0144M |
| February 28, 2017 | -0.0147M |
| November 30, 2016 | -0.0307M |
| August 31, 2016 | -0.0201M |
| May 31, 2016 | -0.0114M |
| February 29, 2016 | -0.052M |
| November 30, 2015 | 0.6817M |
| August 31, 2015 | 0.6848M |
| May 31, 2015 | 0.6293M |
| February 28, 2015 | 0.6388M |
| November 30, 2014 | -0.108M |
| July 31, 2014 | -0.1142M |
| April 30, 2014 | -0.0628M |
| January 31, 2014 | -0.0585M |
| October 31, 2013 | -0.0706M |
| July 31, 2013 | -0.0914M |
| April 30, 2013 | -0.2932M |
| January 31, 2013 | -0.2661M |
| October 31, 2012 | -0.2741M |
| July 31, 2012 | -0.9686M |
| April 30, 2012 | -0.7667M |
| January 31, 2012 | -0.806M |
| October 31, 2011 | -1.003M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.278M
Minimum
Feb 2020
0.2435M
Maximum
Feb 2021
-0.212M
Average
-0.1564M
Median
Cash from Investing (TTM) Benchmarks
| Aurinia Pharmaceuticals Inc | -6.706M |
| Sunshine Biopharma Inc | -0.6562M |
| Acasti Pharma Inc | -1.452M |
| Edesa Biotech Inc | 0.00 |
| Xenon Pharmaceuticals Inc | -117.17M |